The Inference Gap: Red Door's Context-Aware Clinical Decision Support for Multi-Morbidity Patients

Introduction: The Silent Failure of Single-Disease Logic

When a patient presents with type 2 diabetes, chronic kidney disease (CKD) stage 3, and osteoarthritis, the clinical team faces a puzzle that no single guideline can solve. The diabetes guideline recommends metformin, but the CKD guideline suggests caution with renal clearance. The osteoarthritis guideline advises NSAIDs, which conflict with both the kidney and glucose management plans. This is not an edge case—it is the everyday reality for a growing number of patients. As of May 2026, many industry surveys suggest that over 40% of adults over 65 have three or more chronic conditions, yet most clinical decision support systems (CDSS) remain rooted in single-disease logic. The result is what we call the 'inference gap': the space where population-level evidence fails to translate into safe, individualized recommendations for multi-morbidity patients.

Red Door's approach to context-aware CDSS aims to fill this gap by moving beyond simple rule stacking. Instead of treating each condition separately, the system evaluates interactions, treatment burden, and patient priorities. This guide will walk you through the core concepts, compare available approaches, and provide a step-by-step framework for implementing or evaluating such a system. We will also explore anonymized scenarios that reveal common pitfalls and how to avoid them. By the end, you should have a clear understanding of what context-aware CDSS means in practice and how it can reduce harm for the most complex patients.

This overview reflects widely shared professional practices as of May 2026; verify critical details against current official guidance where applicable. The content is for general informational purposes and does not constitute medical or clinical advice. Readers should consult qualified professionals for patient-specific decisions.

Core Concepts: Understanding the Inference Gap and Context-Aware Reasoning

The inference gap arises because clinical guidelines are typically derived from randomized controlled trials that exclude patients with multiple comorbidities. When a CDSS applies a single-disease algorithm to a multi-morbidity patient, it may generate recommendations that are logically correct for each condition but collectively harmful. For example, a system might flag a patient as needing tighter glucose control based on diabetes guidelines, while simultaneously flagging the same patient for hypotension management from heart failure guidelines—without recognizing that the recommended medications for each condition may cancel each other out or cause dangerous side effects.

Why Traditional CDSS Falls Short

Traditional CDSS relies on explicit rule sets: if A, then B. For a patient with hypertension and asthma, a rule might correctly suggest avoiding beta-blockers. But when you add CKD, depression, and osteoporosis, the rule interactions explode combinatorially. Most systems are not designed to handle this complexity. They also lack temporal awareness—a patient's hemoglobin A1c trend over three years tells a different story than a single lab value. Context-aware systems, like those pioneered by Red Door, incorporate multiple dimensions: disease severity, treatment burden, patient goals, and longitudinal data. They do not simply add more rules; they use a reasoning framework that prioritizes safety and quality of life over strict adherence to single-disease targets.

For instance, consider a 72-year-old woman with heart failure, type 2 diabetes, and chronic pain. A conventional CDSS might recommend aggressive glucose lowering (HbA1c target